Menu
GeneBe

TFR2

transferrin receptor 2, the group of M28 metallopeptidases

Basic information

Region (hg38): 7:100620415-100642779

Links

ENSG00000106327NCBI:7036OMIM:604720HGNC:11762Uniprot:Q9UP52AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • hemochromatosis type 3 (Strong), mode of inheritance: AR
  • hemochromatosis type 3 (Strong), mode of inheritance: AR
  • hemochromatosis type 3 (Supportive), mode of inheritance: AR
  • hemochromatosis type 3 (Definitive), mode of inheritance: AR
  • hemochromatosis type 3 (Definitive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Hemochromatosis, type 3ARBiochemical; Gastrointestinal; HematologicPreventive measures and treatment of iron overload (by phlebotomy) can be beneficialBiochemical; Cardiovascular; Endocrine; Gastrointestinal; Hematologic10216143; 10802645; 12150153; 12130528; 19549277; 20542038; 21770687
Variants may also modify hemochromatosis due to mutations in other genes (eg, HFE)

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the TFR2 gene.

  • Hereditary hemochromatosis (648 variants)
  • Hemochromatosis type 3 (196 variants)
  • Inborn genetic diseases (34 variants)
  • not provided (26 variants)
  • not specified (7 variants)
  • Hemochromatosis type 1 (5 variants)
  • TFR2-related condition (2 variants)
  • Hereditary hemochromatosis type 4 (1 variants)
  • Hereditary hemochromatosis type 5 (1 variants)
  • Hemochromatosis, type 1, modifier of (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the TFR2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
3
clinvar
313
clinvar
5
clinvar
321
missense
1
clinvar
3
clinvar
101
clinvar
9
clinvar
1
clinvar
115
nonsense
11
clinvar
15
clinvar
26
start loss
1
clinvar
1
frameshift
25
clinvar
20
clinvar
45
inframe indel
2
clinvar
1
clinvar
3
splice donor/acceptor (+/-2bp)
2
clinvar
24
clinvar
26
splice region
1
10
58
3
72
non coding
11
clinvar
75
clinvar
13
clinvar
99
Total 39 64 117 397 19

Highest pathogenic variant AF is 0.0000526

Variants in TFR2

This is a list of pathogenic ClinVar variants found in the TFR2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
7-100620422-A-G Hemochromatosis type 3 Uncertain significance (Jan 12, 2018)908971
7-100620577-T-G Hemochromatosis type 3 Uncertain significance (Jan 13, 2018)908972
7-100620637-G-A Hemochromatosis type 3 Uncertain significance (Jan 13, 2018)358280
7-100620649-G-A Hemochromatosis type 3 Uncertain significance (Jan 13, 2018)358281
7-100620715-C-T Hemochromatosis type 3 Uncertain significance (Jan 13, 2018)909842
7-100620716-G-A Hemochromatosis type 3 Uncertain significance (Jan 13, 2018)909843
7-100620741-G-A Hemochromatosis type 3 Likely benign (Jan 13, 2018)358282
7-100620802-C-T Hemochromatosis type 3 Uncertain significance (Jan 13, 2018)909844
7-100620856-C-T Hemochromatosis type 3 Uncertain significance (Jan 13, 2018)909845
7-100620863-G-A Hereditary hemochromatosis • Hemochromatosis type 3 Likely benign (Jan 07, 2024)755472
7-100620867-T-C Inborn genetic diseases Uncertain significance (Mar 17, 2023)2526394
7-100620869-A-G Hereditary hemochromatosis Likely benign (Dec 18, 2023)2703930
7-100620874-T-C Hereditary hemochromatosis Likely benign (Jan 25, 2024)415944
7-100620881-G-A Hereditary hemochromatosis Likely benign (Jul 31, 2022)2422097
7-100620884-A-G Hereditary hemochromatosis Likely benign (Apr 07, 2023)2884847
7-100620887-C-T Hereditary hemochromatosis • TFR2-related disorder Likely benign (Dec 19, 2023)1101648
7-100620889-C-T Hemochromatosis type 3 • Hereditary hemochromatosis Likely pathogenic (Jan 11, 2024)21374
7-100620890-G-A Hereditary hemochromatosis Likely benign (Jan 05, 2024)1948796
7-100620896-C-T Hereditary hemochromatosis • Hemochromatosis type 3 Conflicting classifications of pathogenicity (Jan 16, 2024)358283
7-100620908-C-T Hereditary hemochromatosis Likely benign (Jan 13, 2024)1139303
7-100620914-C-T Hereditary hemochromatosis Likely benign (Aug 18, 2023)1107880
7-100620917-C-A Hereditary hemochromatosis Likely benign (Nov 01, 2023)2773179
7-100620917-C-T Hereditary hemochromatosis • Hemochromatosis type 3 Likely benign (Jan 28, 2024)695830
7-100620919-T-C Inborn genetic diseases Uncertain significance (Jun 24, 2022)2296613
7-100620920-C-T Hereditary hemochromatosis • Hemochromatosis type 3 Pathogenic/Likely pathogenic (Jul 17, 2023)859038

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
TFR2protein_codingprotein_codingENST00000462107 1822364
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.29e-90.9971256890591257480.000235
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.154014710.8520.00002845109
Missense in Polyphen127170.180.746281801
Synonymous1.181842060.8950.00001321663
Loss of Function2.722139.40.5330.00000191416

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.001180.00114
Ashkenazi Jewish0.000.00
East Asian0.0001160.000109
Finnish0.000.00
European (Non-Finnish)0.0001310.000123
Middle Eastern0.0001160.000109
South Asian0.0001960.000196
Other0.0001630.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: Mediates cellular uptake of transferrin-bound iron in a non-iron dependent manner. May be involved in iron metabolism, hepatocyte function and erythrocyte differentiation.;
Pathway
Iron metabolism in placenta;Transferrin endocytosis and recycling;Transport of small molecules;Iron uptake and transport (Consensus)

Intolerance Scores

loftool
0.713
rvis_EVS
-0.53
rvis_percentile_EVS
20.91

Haploinsufficiency Scores

pHI
0.397
hipred
N
hipred_score
0.432
ghis
0.637

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
S
essential_gene_gene_trap
gene_indispensability_pred
E
gene_indispensability_score
0.887

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Tfr2
Phenotype
hematopoietic system phenotype; liver/biliary system phenotype; immune system phenotype; growth/size/body region phenotype; homeostasis/metabolism phenotype;

Zebrafish Information Network

Gene name
tfr2
Affected structure
muscle
Phenotype tag
abnormal
Phenotype quality
increased amount

Gene ontology

Biological process
iron ion transport;cellular iron ion homeostasis;receptor-mediated endocytosis;acute-phase response;response to iron ion;transferrin transport;positive regulation of endocytosis;positive regulation of transcription by RNA polymerase II;iron ion homeostasis;cellular response to iron ion;positive regulation of peptide hormone secretion;positive regulation of protein maturation
Cellular component
plasma membrane;integral component of plasma membrane;external side of plasma membrane;cytoplasmic vesicle;HFE-transferrin receptor complex
Molecular function
transferrin receptor activity;protein binding;transferrin transmembrane transporter activity;co-receptor binding